Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
FAQs about Glenmark Pharmaceuticals share price
Glenmark Pharmaceuticals is trading at 1700.15 as on Fri Sep 06 2024 09:59:27. This is -0.53% lower as compared to its previous closing price of 1709.25.
The market capitalization of Glenmark Pharmaceuticals is 47976.22 Cr as on Fri Sep 06 2024 09:59:27.
The average broker rating on Glenmark Pharmaceuticals is Buy. The breakup of analyst rating is given below -
- 4 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 3 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Glenmark Pharmaceuticals is 1750.00 whereas the 52 wk low is 722.25
Glenmark Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: -
- Sector P/E: 31.02
- Dividend Yield: 0.15%
- D/E ratio: -
Glenmark Pharmaceuticals reported a net profit of -1501.67 Cr in 2024.
Glenmark Pharmaceuticals Quick Links
Glenmark Pharmaceuticals Dividend Glenmark Pharmaceuticals Bonus Glenmark Pharmaceuticals News Glenmark Pharmaceuticals AGM Glenmark Pharmaceuticals Rights Glenmark Pharmaceuticals Splits Glenmark Pharmaceuticals Board Meetings Glenmark Pharmaceuticals Key Metrics Glenmark Pharmaceuticals Shareholdings Glenmark Pharmaceuticals Profit Loss Glenmark Pharmaceuticals Balance Sheet Glenmark Pharmaceuticals Cashflow Glenmark Pharmaceuticals Q1 Results Glenmark Pharmaceuticals Q2 Results Glenmark Pharmaceuticals Q3 Results Glenmark Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks